By Mrinalika Roy Oct 28 (Reuters) - Women in the US struggling to find hormone replacement treatments to manage menopause ...

Postmenopausal women are at greater risk for multiple health issues, such as hip fractures and urinary tract infections (UTIs ...

Women are struggling to fill estrogen patch prescriptions as a shortage affecting nearly 20 formulations drags on. Here's why ...

Hormonal changes during the menopausal transition can lead to an increase in pain sensitivity and inflammation. The reason is ...

Bone mineral density significantly decreases during and after menopause due to dropping levels of estrogen. Historically, ...

The FDA is facing mounting pressure to declare an estrogen patch shortage as some medical providers say production isn't keeping up with demand.

Women with a history of recurrent urinary tract infections were more likely to report perioperative vaginal estrogen use and ...

Years after warnings that estrogen therapy could lead to increased cancer risk, a new study has found that it in addition to alleviating hot flashes and other symptoms of menopause, it carries little ...

Sen. Kirsten Gillibrand is calling for the FDA to answer the question of why women can't fill estrogen patch prescriptions a year into supply problems.

Up to 84% of postmenopausal women will experience it.

In November, the FDA removed the black box labeling from estrogen-based HRT and the market pounced. “Trying to find estrogen patches right now is like a high-stakes scavenger hunt that nobody ...

Women with vaginal atrophy have a higher risk of UTIs because thinning tissues make it easier for harmful bacteria to invade ...